Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Board/Management Information 2025

Aug 18, 2025

65285_rns_2025-08-18_cfa3e7eb-2258-4c09-b26c-8d1df2e26958.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

ASX Announcement

19 August 2025

==> picture [104 x 26] intentionally omitted <==

CFO TRANSITION

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions, today advises that its Chief Financial Officer (CFO) Dyan O’Herne will step down from the position, effective 30 September 2025.

The Board would like to thank Ms O’Herne for the valuable contribution she has made to the Company over the past nine years. As CFO since January 2023, Ms O’Herne played an important role in leading Mach7’s finance function and strengthening its financial and operational platform. The Board wishes Ms O’Herne all the best in her future endeavours.

Mach7 has commenced a search for a new CFO and will update the market when an appointment has been made.

Released on authority of the Board of Mach7 Technologies Limited.

For more information, contact:

Investor Relations Françoise Dixon +61 (0) 412 292 977 [email protected]

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a leading provider of medical imaging software, delivering advanced data management and diagnostic viewing solutions to healthcare organisations worldwide. The Mach7 Enterprise Imaging Solution (EIS) is a next-generation solution combining a powerful Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer, and robust diagnostic workflow applications. Built for maximum flexibility and scalability, Mach7 empowers customers to implement a complete enterprise imaging ecosystem or deploy modular components that fit their unique needs. Today, Mach7 supports a diverse global network, from large integrated delivery networks (IDNs) and national health systems to independent provider groups and private radiology practices. Visit Mach7t.com for more information.

1

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

Forward-looking statements

This announcement may contain forward-looking statements regarding the Company’s financial position, business strategy and objectives (rather than being based on historical or current facts). Any forward-looking statements are based on the current beliefs of the Company’s management as well as assumptions made by, and information currently available to, the Company’s management. Forward-looking statements are inherently uncertain and must be read accordingly. There can be no assurance that some or all of the underlying assumptions will prove to be valid.

All data presented in this announcement reflects the current views of the Company with respect to future events. Forward-looking statements are subject to risk, uncertainties and assumptions relating to the operations, results of operations, growth strategy and liquidity of the Company. To the maximum extent permitted by law, the Company, its officers, employees and agents do not accept any obligation to release any updates or revisions to the information (including any forward-looking statements) in this announcement to reflect any change to expectations or assumptions; and disclaim all responsibility and liability for any loss arising from reliance on this announcement or its contents.

==> picture [150 x 53] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 T: 03 9692 7222 www.mach7t.com

2